PEN:NYSE
Penumbra Inc
$319.40
arrow_upward
+0.59%(+1.88) 1D
Okt 9, 4:00:04 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa PEN...
Buksan
$317.06
Mataas
$319.53
Mababa
$317.06
Mkt. cap
12.58B
Avg. na dami
363.86K
Dami
555.30K
P/E ratio
78.45
Mataas nang 52-wk
$362.41
Mababa nang 52-wk
$221.26
EPS
$4.07
Beta
0.70
Mga natitirang share
39.39M
Bilang ng mga empleyado
5K
Buksan
$317.06
Mataas
$319.53
Mababa
$317.06
Mkt. cap
12.58B
Avg. na dami
363.86K
Dami
555.30K
P/E ratio
78.45
Mataas nang 52-wk
$362.41
Mababa nang 52-wk
$221.26
EPS
$4.07
Beta
0.70
Mga natitirang share
39.39M
Bilang ng mga empleyado
5K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Simply Wall Street
·
20 oras ang nakalipas
Will Wearable Recovery Data Change Penumbra Stock Narrative
AD HOC NEWS
·
2 araw ang nakalipas
Penumbra presented STORM-PE data while Penumbra stock trades at EUR 281.30
Profile
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end. Wikipedia
Tungkol sa Penumbra Inc